Actively Recruiting

Age: 18Years - 100Years
All Genders
ID05723718

Malnutrition Assessment With Bioelectrical Impedance Analysis in Gastric Cancer Patients Undergoing Multimodal Treatment - MOONRISE Study

Led by Medical University of Lublin · Updated on 2023-02-13

125

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Medical University of Lublin

Lead Sponsor

E

Erasmus Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying how nutritional status and body composition affect tumor regression in patients with gastric cancer undergoing multimodal treatment. This observational study aims to determine if bioelectrical impedance analysis, a non-invasive method for measuring body composition, can be used as a reliable tool to support clinical decisions for these patients. The study involves patients with locally advanced gastric adenocarcinoma who are scheduled to receive multimodal therapy. The study will include 125 patients who will each have their nutritional status assessed four times at specific points during their treatment: before staging laparoscopy or chemotherapy qualification, before gastrectomy surgery, one month after surgery, and after completing adjuvant chemotherapy. Assessments will include clinical variables such as weight and BMI, bioelectrical impedance analysis, and laboratory tests. Participants will be monitored for tumor regression grade up to 2-4 weeks after surgery. Additional outcomes include chemotherapy toxicity, postoperative complications, overall survival up to 10 years, and quality of life over about three years. The study involves multiple evaluations to track changes in nutritional status and body composition throughout the treatment period, helping researchers understand their impact on treatment outcomes.

CONDITIONS

Brief Title

MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Histologically confirmed gastric adenocarcinoma or undifferentiated carcinoma
  • Stage II or III gastric cancer based on the 8th edition of TNM classification
  • Scheduled for multimodal treatment as decided by a multidisciplinary tumor board
Not Eligible

You will not qualify if you...

  • Early gastric cancer scheduled for endoscopic treatment
  • Gastric stump carcinoma
  • Presence of distant metastasis
  • Planned upfront surgery without multimodal treatment
  • Other malignancies
  • Contraindications to bioelectrical impedance analysis such as implanted cardiac devices, metal implants, or pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - From inclusion through completion of multimodal treatment

Participants undergo four nutritional status assessments including weight, BMI, nutritional status scales, bioelectrical impedance analysis, and laboratory parameters throughout their multimodal treatment.

4 visits corresponding to (1) prior to staging laparoscopy or neoadjuvant chemotherapy qualification, (2) one day before gastrectomy, (3) one month after gastrectomy, and (4) after the last cycle of adjuvant chemotherapy

Long-term Monitoring

Duration - Up to 10 years

Participants are observed for overall survival and quality of life following surgery and multimodal treatment.

Visits scheduled as part of routine follow-up care

Trial Site Locations

Total: 1 location

1

Medical University of Lublin

Lublin, Poland, 20-080

Actively Recruiting

Loading map...

Research Team

Z

Zuzanna Pelc, PhD

K

Karol Rawicz-Pruszyński, Professor

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Phase III Randomized Controlled Trial Comparing D2 Versus D3...

Gastric Cancer

Actively Recruiting

1 location

Clinical Outcomes of Indocyanine Green Tracer in 3D Plus Ult...

Gastric Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

MalnutritiOn assessment with biOelectrical impedaNce analysis in gastRic cancer patIentS undergoing multimodaltrEatment (MOONRISE)-Study protocol for a single-arm multicenter cross-sectional longitudinal study.

Zuzanna Pelc, Katarzyna Sędłak, Radosław Mlak...

https://pubmed.ncbi.nlm.nih.gov/38319910